LMS receives Health Canada clearance for standalone offering of CALM Curve
September 28 2006 - 9:00AM
PR Newswire (US)
MONTREAL, QC, Sept. 28 /PRNewswire-FirstCall/ -- LMS Medical
Systems (AMEX:LMZ; TSX:LMZ), a healthcare technology company and
developer of the CALM(TM) clinical information system and risk
prevention and reduction software tools for obstetrics announced
today that it has received clearance by Health Canada to market its
CALM Curve(TM) software in a standalone fashion, independent from
previously prerequisite supporting platforms and infrastructure.
With this Health Canada clearance, CALM Curve will be available
through a seamless web offering similar to the CALM Shoulder
Screen(TM) application. Originally, Curve was available only as an
integrated component of the CALM clinical information system.
Clinical teams will now be able to use the tools independently
from, and irrespective of, any obstetrical or central hospital
information system that may be in use. CALM Curve is a computerized
method of providing consistent and objective evaluation of labor
progress. In some cases, it can therefore be used to confirm the
need for a cesarean for women demonstrating symptoms of dystocia
(slow labor). In other cases, as concluded in cross border clinical
studies involving some 11,000 first time mothers, the use of CALM
Curve, when introduced, contributed to a safe fall in cesarean
rates from 19.54% to 16.62% at 12 months (P equals 0.00006). CALM
Curve can provide meaningful assistance to Canadian and U.S.
clinical teams, where cesarean section rates respectively exceeded
25% and 29% in 2005. Another clinical situation, prevalent in
litigation, involves the management of labor in women who have had
a previous cesarean. Uterine rupture is a catastrophic complication
with a reported incidence ranging from 0.2 to 1.5% in these women.
Complications associated with uterine rupture include hysterectomy,
fetal death and permanent fetal injury. In a retrospective analysis
using the CALM Curve, abnormal labor progress was identified in 42%
of cases of uterine rupture. This diagnosis was apparent, on
average, five hours before the rupture, providing ample time for
health care professionals to intervene and avoid this complication.
"Being able to offer the CALM Curve through the web along with the
CALM Shoulder Screen is another avenue to reach out to clinicians
and healthcare institutions in search of excellence," stated Diane
Cote, CEO of LMS. "We continue to pursue innovative ways and means
to improve outcomes and patient safety without the need for
infrastructural investment on the part of the user." About LMS: LMS
is a leader in the application of advanced mathematical modeling
and neural networks for medical use. The LMS CALM(TM) Decision
Support Suite provides physicians, nursing staff, risk managers and
hospital administrators with clinical information systems and risk
prevention and reduction tools designed to improve outcomes and
patient care for mothers and their infants during childbirth.
Except for historical information contained herein, the matters
discussed in this news release are forward-looking statements.
Because these forward-looking statements involve risks and
uncertainties, there are important factors that could cause actual
results to differ materially from those expressed implied by the
forward-looking statements including, but without limitation,
economic conditions in general and in the healthcare market, the
demand for and market for our products in domestic and
international markets, our current dependence on the CALM product
suite, the challenges associated with developing new products and
obtaining regulatory approvals if necessary, research and
development activities, the uncertainty of acceptance of our
products by the medical community, the lengthy sales cycle for our
products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by
others, our dependence on our distributors, physician training,
enforceability and the costs of enforcement of our patents,
potential infringements of our patents and the other factors set
forth from time to time in the Company's filings with the United
States Securities and Exchange Commission and with the Canadian
Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Andrea Miller,
Communications, LMS Medical Systems Inc., (514) 488-3461, Ext. 222,
Fax: (514) 488-1880, ; http://www.lmsmedical.com/; David
Gordon/Grant Howard, The Howard Group Inc., Toll free:
1-888-221-0915, ; http://www.howardgroupinc.com/
Copyright